Living with chronic pain is not just about discomfort — it is about losing parts of daily life. When pain lasts longer than three to six months and does not respond to medications, injections, therapy, or even surgery, it becomes chronic. Over time, the nervous system can change, amplifying pain signals and making relief harder to achieve. Sleep suffers. Mood declines. Work, relationships, and independence can all be affected, and frustration or fear about the future may grow.
For many people caught in this cycle, traditional treatments no longer provide meaningful relief. This is where neuromodulation — specifically Spinal Cord Stimulation (SCS) — offers a different path forward by targeting the nervous system itself to alter how pain signals are processed.
The journey typically begins with a trial period lasting up to 30 days. During this phase, a temporary stimulator is used to assess whether SCS provides meaningful relief before recommending permanent implantation. Patients track pain levels, activity, sleep, and medication use to evaluate real‑world benefits.
Spinal Cord Stimulation (SCS) uses gentle electrical signals delivered near the spinal cord to modify how pain signals travel to the brain. Instead of pain dominating awareness, stimulation helps the nervous system interpret signals differently, reducing the sensation of pain and supporting improved function and comfort. SCS is commonly used for chronic pain affecting the trunk, back, or limbs when other treatments have failed.
The Nalu Neurostimulation System is a miniaturized, battery‑free implantable pulse generator (IPG) powered wirelessly by an externally worn Therapy Disc and controlled through a smartphone‑based app. This innovative design allows the system to deliver stimulation comparable to larger implanted devices while maximizing comfort and programmability.
The Nalu SCS System is designed with features that reflect modern neuromodulation priorities:
These features combine to provide a flexible, adaptable therapeutic platform while minimizing the burden of traditional implanted battery systems.
The Nalu SCS System is indicated for chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain, and is intended to be used as part of a broader, multidisciplinary approach to pain management.
The process begins with a thorough evaluation by a pain specialist. A temporary lead or stimulator is placed and used for up to 30 days to assess effectiveness. Patients track changes in pain, sleep, activity, and medication use.
If the trial demonstrates meaningful relief, a permanent implant is placed. Patients are educated on how the Nalu system works, how to wear and use the external Therapy Disc, and how to interact with the smartphone app.
Follow‑up visits ensure optimal programming and continued effectiveness. Over time, patients gradually return to activities they may have reduced due to pain, supported by ongoing clinical care.
Nalu provides education materials to help patients understand:
Chronic pain does not have to define a person’s future. For many individuals, SCS with the Nalu Neurostimulation System offers a modern, adaptable solution focused on restoring function, hope, and quality of life.